key: cord-0847417-nmk8hrnz
authors: Piccerillo, Alfredo; Fossati, Barbara; Cappilli, Simone; Sollena, Pietro
title: Dermatologic surgery in the COVID‐19 era: observations and practical suggestions
date: 2020-06-18
journal: Dermatol Ther
DOI: 10.1111/dth.13873
sha: 40988c9f0b5b9e3f386a6a7f0e616ad0b625a48d
doc_id: 847417
cord_uid: nmk8hrnz

nan

melanoma or for a highly suspicious melanocytic lesion, then surgical excision must be performed promptly, in accordance with availability of operating rooms and anesthesiologists ( Figure 1 ). Accounting for non-melanocytic skin cancers (NMSCs) and focusing in particular on suspicious low risk basal cell carcinomas (BCCs) (trunk and extremities lesions, welldefined borders, primary lesions, nodular or superficial histologic subtypes, no perineural involvement in a previous incisional biopsy) 5 we recommend to defer treatment by 4-6 months, since these tumors have a slow-growing behavior not influencing the prognosis outcome; high risk BCCs (head and neck lesions, poorly defined borders, recurrent lesions, BCC in immunosuppressed patients or grown on site of prior radiation therapy, aggressive histologic subtypes or perineural involvement in a previous incisional biopsy) should be excised, since a deferring may lead to significant morbidity and disfigurement. In the management of suspicious squamous cell carcinomas (SCCs), surgical excision should be scheduled for ulcerated and symptomatic lesions, rapidly-enlarging tumors, lesions occurring in patients with significant risk factors (immunosuppression, site of prior radiotherapy or chronic inflammatory process) and head and neck lesions, while it seems reasonable to postpone by 4-6 months radical excision for low risk SCCs (primary, well differentiated lesions, with well-defined borders, located on the trunk or extremities). 6 Having accurately selected lesions to excise, it is important to stagger appointments in order to minimize number of patients attending waiting room together. All patients should undergo contactless body temperature scanning before getting into the clinic (body temperature must be <37.5°C) and complete a specific form declaring to have had no flu-like symptoms neither contact with COVID-19 positive individuals in the last two weeks. Furthermore, patients need This article is protected by copyright. All rights reserved.

to wear surgical face mask and gloves and keep them during the surgical procedure whenever possible. It is mandatory for HCWs to wear surgical face mask, eye screen, apron and gloves; FFP2 masks are essential for all cases of close, face-to-face contact with patients, such as surgical procedures performed on the head and neck area.

These general recommendations on dermatologic surgery might be subjected to further modifications according to the evolutions of the COVID-19 pandemic, in order to ensure safety of both HCWs and patients.

This article is protected by copyright. All rights reserved. mm) showing irregular borders and multiple colors, located on the extensor surface of the right arm (Fig 1a) . Dermoscopic examination showed a multi-component pattern, with atypical pigment network, shiny white streaks, milky-red areas, peppering and blue-whitish veil (Fig 1b) . Clinic-dermoscopical examination was highly suspected for melanoma, patient underwent surgical excision (Fig 1c) and histological examination showed melanoma 1.1 mm Breslow thickness.

This article is protected by copyright. All rights reserved. 

WHO Coronavirus disease (COVID-19) outbreak situation

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)

British Association of Dermatologists and British Society for Dermatological Surgery. Clinical Guidance for the Management of Skin Cancer Patients During the Coronavirus Pandemic

The COVID-19 Outbreak in Dermatologic Surgery: Resetting Clinical Priorities

NCCN Clinical Practice Guidelines in Oncology

Low risk basal cell carcinomas (BCCs) 1 Defer surgical excision by 4-6 months High risk BCCs 2 Surgical excision Low risk squamous cell carcinomas (SCCs) 3 Defer surgical excision by 4-6 months High risk SCCs 4 Surgical excision Benign lesions Defer surgical excision by 4-6 months